Stock Events

Stock Events

Neurizon Therapeutics 

$0.11
0
+$0.03+38.17% Thursday 20:46

Statistics

Day High
0.11
Day Low
0.11
52W High
0.12
52W Low
0.07
Volume
9,000
Avg. Volume
5
Mkt Cap
58.94M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-21.54MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NUZTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.57B
Zai Lab Limited operates in the biopharmaceutical sector focusing on developing and commercializing therapies that address significant unmet medical needs, similar to Pharmaust's focus on innovative cancer treatments.
Macrogenics
MGNX
Mkt Cap193.86M
MacroGenics, Inc. develops monoclonal antibody-based therapeutics for the treatment of cancer, aligning closely with Pharmaust's work in cancer therapeutics.
Karyopharm Therapeutics
KPTI
Mkt Cap195.23M
Karyopharm Therapeutics Inc. is involved in the discovery and development of drugs for the treatment of cancer, competing in the same therapeutic area as Pharmaust.
TG Therapeutics
TGTX
Mkt Cap5.85B
TG Therapeutics, Inc. focuses on B-cell malignancies and autoimmune diseases, competing with Pharmaust in the broader oncology and therapeutic market.
Array Technologies
ARRY
Mkt Cap1.24B
Array BioPharma Inc. specializes in the development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, similar to Pharmaust's strategic focus.

About

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Show more...
CEO
Dr. Michael Thurn Ph.D.
Country
United States
ISIN
AU0000357261

Listings

OTC Link
US
NUZTF
STU
DE
ECQ0.STU
F
DE
ECQ0.F
AU
AU
NUZ.AU

0 Comments

Share your thoughts

FAQ

What is Neurizon Therapeutics stock price today?▼
The current price of NUZTF is $0.11 USD — it has increased by +38.17% in the past 24 hours. Watch Neurizon Therapeutics stock price performance more closely on the chart.
What is Neurizon Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neurizon Therapeutics stocks are traded under the ticker NUZTF.
What is Neurizon Therapeutics market cap?▼
Today Neurizon Therapeutics has the market capitalization of 58.94M
What is Neurizon Therapeutics revenue for the last year?▼
Neurizon Therapeutics revenue for the last year amounts to 0 USD.
What is Neurizon Therapeutics net income for the last year?▼
NUZTF net income for the last year is -21.54M USD.
In which sector is Neurizon Therapeutics located?▼
Neurizon Therapeutics operates in the Other sector.
When did Neurizon Therapeutics complete a stock split?▼
Neurizon Therapeutics has not had any recent stock splits.
Where is Neurizon Therapeutics headquartered?▼
Neurizon Therapeutics is headquartered in Melbourne, United States.